Analysis of potential predictive markers of cetuximab benefit in BMS099, a phase III study of cetuximab and first-line taxane/carboplatin in advanced non-small-cell lung cancer (Q43184359)
Jump to navigation
Jump to search
scientific article published on 25 January 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Analysis of potential predictive markers of cetuximab benefit in BMS099, a phase III study of cetuximab and first-line taxane/carboplatin in advanced non-small-cell lung cancer |
scientific article published on 25 January 2010 |
Statements
1 reference
Analysis of potential predictive markers of cetuximab benefit in BMS099, a phase III study of cetuximab and first-line taxane/carboplatin in advanced non-small-cell lung cancer (English)
1 reference
Shirin Khambata-Ford
1 reference
Christopher T Harbison
1 reference
Lowell L Hart
1 reference
Melissa Awad
1 reference
Li-An Xu
1 reference
Christine E Horak
1 reference
Shaker Dakhil
1 reference
Robert C Hermann
1 reference
Thomas J Lynch
1 reference
Martin R Weber
1 reference
25 January 2010
1 reference
1 reference
Identifiers
1 reference